Altered Plakoglobin Expression at mRNA and Protein Levels Correlates with Clinical Outcome in Patients with Oropharynx Squamous Carcinomas

Human Pathology

Volumn 35, Issue 1, 2004, Pages 75-85

  Papagerakis, Silvana ^a   Shabana, Al Hassan ^b   Depondt, Joël ^b   Pibouin, Laurence ^b   Blin Wakkach, Claudine ^b   Berdal, Ariane ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

Adhesion; Catenin; Oropharynx; Plakoglobin; Prognosis; RNA; Squamous cell carcinoma

Indexed keywords

MESSENGER RNA; PLAKOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; OROPHARYNX CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

EID: 1642499131     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.08.018     Document Type: Article

References (51)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841, 1999
2. Lacy PD, Piccirillo JF, Merritt MG, et al: Head and neck squamous cell carcinoma: Better to be young. Otolaryngol Head Neck Surg 122:253-258, 2000
3. Behrens J: Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Metastasis Rev 18:15-30, 1999
4. Hatzfeld M: The armadillo family of structural proteins. Int Rev Cytol 186:179-225, 1999
5. Ben-Ze'ev A: The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction. Ann NY Acad Sci 886:37-47, 1999
6. Simcha I, Shtutman M, Salomon D, et al: Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 141:1433-1448, 1998
7. Franke WW, Goldschmidt MD, Zimbelmann R, et al: Molecular cloning and amino acid sequence of human plakoglobin, the common junctional plaque protein. Proc Natl Acad Sci U S A 86: 4027-4031, 1989
8. Levis JE, Wahl JK III, Sass KM, et al: Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol 136:919-934, 1997
9. Pannone G, Lo Muzio L, Bucci P, et al: Psysiopathology of beta and gamma catenin in the oral epithelium. Minerva Stomatol 47:583-588, 1998
10. Williams HK, Sanders DSA, Jankowski JAZ, et al: Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 27:308-317, 1998
11. Bagutti C, Speight PM, Watt FM: Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 186:8-16, 1998
12. Lo Muzio L, Staibano S, Pannone G, et al: Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19:3817-3826, 1999
13. Klymkowsky MW, Williams BO, Barish GD, et al: Membrane-anchored plakoglobins have multiple mechanisms of action in wnt signaling. Mol Biol Cell 10;3151-3169, 1999
14. Zhurinsky J, Shtutman M, Ben-Ze'ev A: Plakoglobin and (β)-catenin: Protein interactions, regulation and biological roles. J Cell Sci 113:3127-3139, 2000
15. Hakimelahi S, Parker HR, Gilchrist AJ, et al: Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J Biol Chem 275:10905-10911, 2000
16. Lustig B, Behrens J: The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129:199-221, 2003
17. Aberle H, Bierkamp C, Torchard D, et al: The human plakoglobin gene is localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci U S A 92:6384-6388, 1995
18. Simcha I, Geiger B, Yehuda-Levenberg S, et al: Suppression of tumorigenicity by plakoglobin: An augmenting effect of N-cadherin. J Cell Biol 133;199-209, 1996
19. Charpentier E, Lavker RM, Acquista E, et al: Plakoglobin suppresses epithelial proliferation and hair growth in vivo. J Cell Biol 149:503-520, 2000
20. Depondt J, Shabana AH, Florescu-Zorila S, et al: Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis. Eur J Oral Sci 107:183-193, 1999
21. 3, and p0071) in primary oropharyngeal tumors: Correlation with clinical parameters. HUM PATHOL 34:565-572, 2003
22. Karnofsky DA: Determining the extent of the cancer and clinical planning for cure. Cancer 22:730-734, 1968
23. Altschul SF, Gish W, Miller W, et al: Basic local alignment search tool. Mol Biol 215:403-410, 1990
24. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680, 1994
25. Pindborg JJ, Reichart PA, Smith CJ, et al: Histological typing of cancer and precancer of the oral mucosa, in Sobin LH (ed): World Health Organization Classification of Tumors. Berlin, Springer-Verlag, 1997, pp 11-13
26. Sobin LH, Wittekind CH (eds): International Union Against Cancer (UICC) TNM Classification of Malignant Tumors. New York, Wiley, 1997
27. Hatzfeld M, Green KJ, Sauter H: Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains. J Cell Sci 116:1219-1233, 2003
28. Bierkamp C, McLaughlin KJ, Schwarz H, et al: Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol 180:780-785, 1996
29. Ruiz P, Brinkmann V, Ledermann B, et al: Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol 135:215-225, 1996
30. McKoy G, Protonotarios N, Crosby A, et al: Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119-2124, 2000
31. Nunn J, Scholes AG, Liloglou T, et al: Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN). Carcinogenesis 20:2219-2228, 1999
32. Cowley CM, Simrak D, Spurr NK, et al: The plakophilin 1 (PKP1) and plakoglobin (JUP) genes map to human chromosomes 1q and 17, respectively. Hum Genet 100:486-488, 1997
33. Ben-Ze'ev A: Cytoskeletal and adhesion proteins as tumor suppressors. Curr Opin Cell Biol 9:99-108, 1997
34. Pantel K, Passlick B, Vogt J, et al: Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 16:1407-1413, 1998
35. Endo K, Ueda T, Ueyama J, et al: Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinico-pathologic parameters, and patients' survival. HUM PATHOL 31:558-565, 2000
36. Buchner A, Oberneder R, Riesenberg R, et al: Expression of plakoglobin in renal cell carcinoma. Anticancer Res 18:4231-4235, 1998
37. Syrigos KN, Harrington K, Waxman J, et al: Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer. J Urol 160:1889-1893, 1998
38. Papadavid E, Pignatelli M, Zakynthinos S, et al: Abnormal immunoreactivity of the E-cadherin/catenin (α-, β-, and γ-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol 196:154-162, 2002
39. Ilyas M: Adhesion molecule expression in breast cancer: The phoenix in tumour metastasis? J Pathol 190:3-5, 2000
40. Kolligs FT, Kolligs B, Hajra KM, et al: Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 14:1319-1331, 2000
41. Wijnhoven BP, Dinjens WN, Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87:992-1005, 2000
42. Denk C, Hulsken J, Schwarz E: Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett 120:185-193, 1997
43. Giroldi LA, Bringuier PP, Shimazui T, et al: Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int J Cancer 82:70-76, 1999
44. Bringuier PP, Giroldi LA, Umbas R, et al: Mechanisms associated with abnormal E-cadherin immunoreactivity in human bladder tumors. Int J Cancer 83:591-595, 1999
45. Popov Z, Gil-Diez de Medina S, Lefrere-Belda MA, et al: Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Br J Cancer 83:209-214, 2000
46. Sakaki T, Wato M, Tamura I, et al: Correlation of E-cadherin and alpha-catenin expression with differentiation of oral squamous cell carcinoma. J Osaka Dent Univ 33:75-81, 1999
47. Caca K, Kolligs FT, Ji X, et al: Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/ lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 10:369-376, 1999
48. Whittock NV, Ashton GH, Dopping-Hepenstal PJ, et al: Striate palmoplantar keratoderma resulting from desmoplakin haploin-sufficiency. J Invest Dermatol 113:940-946, 1999
49. Conne B, Stutz A, Vassalli JD: The 3′ untranslated region of messenger RNA: A molecular "hotspot" for pathology? Nat Med 6:637-641, 2000
50. Mignone F, Gissi C, Liuni S, et al: Untranslated region of mRNAs. Genome Biol 3:0004, 2002
51. Mbongolo Mbella EG, Bertrand S, Huez G, et al: A GG nucleotide sequence of the 3′ untranslated region of amyloid precursor protein mRNA plays a key role in the regulation of translation and the binding of proteins. Mol Cell Biol 13:4572-4579, 2000